CROI 2019 Program and Conference Information

Index

519

TENOFOVIR ALAFENAMIDE VS TENOFOVIR DF INWOMEN: POOLED ANALYSIS OF 7 CLINICAL TRIALS (Poster Session P-H6) EFFECT OF ANTIRETROVIRAL THERAPY AND IMMUNE RECONSTITUTION ON VAGINAL MICROBIOME (Poster Session P-H6) DIVERSE OBSTETRICIAN HCV-SCREENING PRACTICES IN A LARGE REGIONAL HEALTH CARE SYSTEM (Poster Session P-K2) THE COST-EFFECTIVENESS OF HCV SCREENING OF PREGNANT WOMEN IN THE UNITED STATES (Poster Session P-K2) NO INCREASE IN BIRTH DEFECTS IN INFANTS EXPOSED TO INTEGRASE INHIBITORS AT CONCEPTION (Poster Session P-P1) EVALUATION OF NEURAL-TUBE DEFECTS AFTER EXPOSURE TO RALTEGRAVIR DURING PREGNANCY (Poster Session P-P1) REPORTS OF NEURALTUBE DEFECTS FOR 8 ARTS, IN FDA, WHO, EMA, AND UK SAFETY DATABASES (Poster Session P-P1) InSTI EXPOSURE AND NEURAL-TUBE DEFECTS: DATA FROM ANTIRETROVIRAL PREGNANCY REGISTRY (Poster Session P-P1) UGANDAN CLINIC EXPERIENCE FOLLOWING POTENTIAL TERATOGENICITY ALERT FOR DOLUTEGRAVIR (Poster Session P-P1) SERUM FOLATE AND BIRTH OUTCOMES: DTG VS EFV TRIAL EVIDENCE IN SOUTH AFRICA (Poster Session P-P1) FETAL BIOMETRY SIMILAR WITH DOLUTEGRAVIR OR EFAVIRENZ EXPOSURE (Poster Session P-P2) ADVERSE BIRTH OUTCOMES AMONG PRENATALLY VS SEXUALLY HIV- INFECTED WOMEN IN BOTSWANA (Poster Session P-P2) ADVERSE PREGNANCY OUTCOMES IN HIV-POSITIVE PREGNANT WOMEN ON ART IN KENYA (Poster Session P-P2) TIMING OF MATERNAL ANTIRETROVIRAL THERAPY INITIATION AND STILLBIRTH IN MALAWI (Poster Session P-P2) PRETERM BIRTH AMONG WOMENWITH ULTRASOUND-BASED GESTATIONAL DATING IN PROMISE 1077BF (Poster Session P-P2) LOPINAVIR (AN HIV PROTEASE INHIBITOR) IMPAIRS UTERINE REMODELING DURING PREGNANCY (Poster Session P-P2) RECENT HIV INFECTION SURVEILLANCE AMONG ADOLESCENT GIRLS AND YOUNG WOMEN IN MALAWI (Poster Session P-R1) HPV VACCINE WITH LEEP DID NOT PREVENT RECURRENT CERVICAL HSIL IN HIV-INFECTED WOMEN (Oral Abstract Session O-01) HIV IS ASSOCIATED WITH DECREASED BREAST CANCER SURVIVAL: A PROSPECTIVE COHORT STUDY (Oral Abstract Session O-01) RANDOMIZED TRIAL OF RALTEGRAVIR-ART VS EFAVIRENZ-ART WHEN INITIATED DURING PREGNANCY (Oral Abstract Session O-04) RCT OF DOLUTEGRAVIR VS EFAVIRENZ-BASED THERAPY INITIATED IN LATE PREGNANCY: DOLPHIN-2 (Oral Abstract Session O-04) MATERNAL HBV VIREMIA IS ASSOCIATED WITH ADVERSE INFANT OUTCOMES IN HIV/HBV WOMEN (Oral Abstract Session O-04) ANTIBIOTIC USE AND VAGINAL DISCHARGE SYNDROME BY HIV STATUS IN PREGNANCY: BOTSWANA (Poster Session P-R2) A NEW PREDICTION MODEL FOR CHLAMYDIA AND GONORRHEA SCREENING INWOMENWITH HIV (Poster Session P-S1)

520

586

589

744

Index of Studies Related toWomen

745

746

747

748

749

750

752

753

754

755

756

831

14

16

39

40

41

854

925

CROI 2019 163